ESC Professional Premium Access

Impact of chronic GLP-1 receptor agonist and SGLT-2 inhibitor therapy on in-hospital outcomes of patients with diabetes mellitus hospitalized with acute myocardial infarction.

Congress Presentation

About the speaker

Mr Filippo Trombara

University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)
0 follower

5 more presentations in this session

Lipoprotein(a) and the effect of alirocumab on coronary and non-coronary revascularization following acute coronary syndrome

Speaker: Professor P. Steg (Paris, FR)


Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and interaction with the vascular endothelium: the impact of PCSK9 inhibition with evolocumab in acute coronary syndrome

Speaker: Doctor E. Ziogos (Baltimore, US)


Quality matters: low-density lipoprotein electronegativity but not quantity determines mortality risk in acute coronary syndromes

Speaker: Doctor S. Kraler (Zurich, CH)


Glycated haemoglobin and the association with long-term survival among patients evaluated for stable angina - a prospective Norwegian cohort

Speaker: Doctor G. Svingen (Bergen, NO)


Cardioprotective effect of empagliflozin in acute myocardial infarction: the role of ketone bodies availability.

Speaker: Professor J. Badimon (New York, US)


Access the full session

What’s new on lipids and diabetes in acute coronary syndrome

Speakers: Mr F. Trombara, Professor P. Steg, Doctor E. Ziogos, Doctor S. Kraler, Doctor G. Svingen...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb